WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...

Cerebral cavernous malformation (CCM) patients treated with oral drug, REC-994, showed reduction in total cerebral and brainstem lesion volume.

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...

The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx ...

The Cannabis Regulatory Agency found medium chain triglyceride (MCT) oil, a prohibited ingredient, in Platinum brand vaping ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

State leaders are reviving talk of importing prescription drugs from Canada, even as US drugmakers and health-care attorneys ...

Confusion between approved injectable epinephrine products and unapproved nasal solutions has prompted a warning to healthcare providers and a recall by one manufacturer, according to a January ...

On January 17, the Drug Enforcement Administration (DEA) and the U.S. Department of Health and Human Services (HHS) jointly published two final ...